Novartis India Forms Death Cross, Signaling Potential Bearish Trend Ahead

Oct 24 2025 06:00 PM IST
share
Share Via
Novartis India Ltd, a small-cap pharmaceutical company, has recently encountered a Death Cross, indicating potential bearish market sentiment. With a market cap of Rs 2,158.00 crore and a P/E ratio significantly below the industry average, the stock has underperformed over the past year, facing ongoing challenges reflected in various technical indicators.
Novartis India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and a bearish trend.

Currently, Novartis India has a market capitalization of Rs 2,158.00 crore and a price-to-earnings (P/E) ratio of 20.74, which is notably lower than the industry average of 35.71. Over the past year, the stock has underperformed, showing a decline of 18.20%, while the Sensex has gained 5.18%. In the short term, Novartis India has also faced challenges, with a 1.50% drop today compared to a 0.41% decline in the Sensex.

The technical indicators paint a bearish picture, with the MACD and Bollinger Bands reflecting negative momentum. The stock's performance over various time frames, including a 3-month decline of 14.93% and a year-to-date drop of 6.13%, further emphasizes the challenges it faces in the current market environment. Investors may want to closely monitor these trends as they could have implications for future performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via